跳至主要内容
临床试验/NCT00221611
NCT00221611已完成2 期

Intrathecal Administration of Baclofen (ITB) to Cerebral Palsy Patients With Therapy-Resistant Spasticity

University Hospital, Ghent2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2000年1月1日最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
80
试验地点
2
主要终点
Spasticity of patients after 4 years

研究概览

简要总结

Evaluation of the effect of intrathecal administration of Baclofen on spasticity of cerebral palsy patients, by means of standardized and internationally accepted scales

详细描述

Evaluation of the effect of intrathecal administration of Baclofen on spasticity of cerebral palsy patients, by means of standardized and internationally accepted scales

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
5 Years 至 25 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • CP patients with therapy-resistent spasticity
  • Patients with sufficient body weight in relation to the volume
  • Oral medication has failed: insufficient effect or too many side-effects
  • The patient and family understand the objectives of the treatment and accept those objectives
  • Informed Consent

排除标准

  • Contra-indications for surgery (e.g. infection)
  • Hypersensitivity to oral Baclofen

结局指标

主要结局

Spasticity of patients after 4 years

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Intrathecal Administration of Baclofen (ITB) to... | 临床试验